Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943.1K

Tokai Pharmaceuticals reports 2018 executive compensation

Published: May 15, 2019

Tokai Pharmaceuticals reported fiscal year 2018 executive compensation information on May 15, 2019.

In 2018, three executives at Tokai Pharmaceuticals received on average a compensation package of $666.1K, a 9% increase compared to previous year.

Average pay of disclosed executives at Tokai Pharmaceuticals

Gregory J. Flesher, Chief Executive Officer, received $943.1K in total, which decreased by 2% compared to 2017. 48.76% of Flesher's compensation, or $459.9K, was in salary. Flesher also received $191.2K in non-equity incentive plan, $191.3K in option awards, $99.3K in stock awards, as well as $1.4K in other compensation.

Catherine C. Turkel, President, received a compensation package of $625.5K, which increased by 9% compared to previous year. 57.18% of the compensation package, or $357.7K, was in salary.

Jon S. Kuwahara, Senior Vice President of Finance and Administration, earned $429.6K in 2018, a 66% increase compared to previous year.